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AVDO2 = arteriovenous difference in oxygen; CaCO2 = arterial carbon dioxide content; CvCO2 = venous carbon dioxide content; etCO2 = end-
tidal carbon dioxide; FiO2 = fractional inspired oxygen; VCO2 = carbon dioxide consumption; VO2 = oxygen consumption.
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Intensive and perioperative care share a common goal, namely
to maintain ‘adequate’ organ perfusion throughout the body
during the time course of critical illness or surgery. Adequate
organ perfusion implies two different physical properties: perfu-
sion pressure that is sufficiently high to force blood into the cap-
illaries of all organs; and sufficient flow to deliver oxygen and
substrates, and to remove carbon dioxide and other metabolic
byproducts. However, in many instances the only aspect of per-
fusion that is carefully monitored is pressure, whereas flow is
simply ignored. One of the reasons for this may be related to the
difficulties encountered in obtaining flow measurements. Indeed,
in many centres the only way to obtain a measure of cardiac
output is to use the thermodilution technique through a pul-
monary artery catheter. The difficulties and risks associated with
pulmonary artery catheter insertion may account, in part, for the
lack of routine cardiac output monitoring in every patient. New
emerging techniques can provide a measure of cardiac output
less invasively than is the case with a pulmonary artery catheter.
The purpose of the present review is to provide an overview
of the new cardiac output measurement techniques, with an
emphasis on their principles of operation and their respective
limitations. We review methods based on Doppler velocime-
try of the descending aorta, the Fick principle applied to
carbon dioxide, and arterial pulse contour analysis.
Oesophageal Doppler
The oesophageal Doppler technique is based on measure-
ment of blood flow velocity in the descending aorta by means
of a Doppler transducer (4 MHz continuous or 5 MHz pulsed
wave, according to the type of device) at the tip of a flexible
probe. The probe may be introduced orally in anaesthetized,
mechanically ventilated patients. Following introduction of the
probe, it is advanced gently until the tip is located approxi-
mately at the mid-thoracic level; it is then rotated so that the
transducer faces the aorta and a characteristic aortic velocity
signal is obtained (Fig. 1). Probe position is optimized by slow
rotation in the long axis and alteration of the depth of insertion
to generate a clear signal with the highest possible peak
velocity. Gain setting is adjusted to obtain the best outline of
the aortic velocity waveform.
Measurement of stroke volume using oesophageal Doppler is
derived from the well established principles of stroke volume
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Abstract
Measuring cardiac output is of paramount importance in the management of critically ill patients in the
intensive care unit and of ‘high risk’ surgical patients in the operating room. Alternatives to
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making cardiac output easily measurable, however, these techniques should all contribute to
improvement in haemodynamic management.
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measurement in the left ventricular outflow tract using
transthoracic echo and Doppler (Fig. 2) [1]. Several assump-
tions are required for transposition of this algorithm from the
left ventricular outflow tract to the descending aorta: accurate
measurement of descending aortic blood flow velocity; a ‘flat’
velocity profile in the descending aorta; an estimated aortic
cross-sectional area close to the mean value during systole; a
constant division of blood flow between the descending aorta
(70%) and the brachiocephalic and coronary arteries (30%);
and, finally, a negligible diastolic flow in the descending aorta.
Accurate velocity measurement requires good alignment
between the Doppler beam and blood flow, and knowledge
of the angle at which the blood flow is insonated. Alignment
is optimal where the signal is the brightest on the spectral
representation (CardioQ, Deltex Medical Ltd, Chichester, UK;
and Waki, Atys Medical, Soucieu en Jarrest, France) or when
the aortic walls are well defined on M-mode echocardiogra-
phy (HemoSonic, Arrow International, Reading, PA, USA),
and when peak velocity is maximum (all devices). The angle
between the Doppler beam and the flow is presumed to be
the same as that between the transducer and the probe (45°
or 60°, depending on the device), because the oesophagus
and aorta are usually parallel in the thorax. A discrepancy
between the true and the theoretical angle is more problem-
atic when the inclination of the transducer is 60°. Indeed, a
discrepancy of 10° will result in an error ranging between
+28% and –32% for a 60° transducer (5 MHz) but only
+16% to –19% for a 45° transducer (4 MHz).
The assumption regarding the velocity profile is that all red
blood cells are moving at approximately the same speed.
The cross-sectional area of the descending aorta can be
measured at the bedside by using transoesophageal
echocardiography; however, this technique is not available in
all centres. The manufacturers of oesophageal Doppler
devices have solved this problem either by incorporating an
M-mode echo transducer into their probe in order to measure
aortic diameter instantaneously (HemoSonic, Arrow) or by
providing a nomogram to estimate the cross-sectional area of
the descending aorta based on the patient’s age, weight and
height (CardioQ, Deltex Medical Ltd; and Waki, Atys
Medical). Systematic errors due to a discrepancy between
the actual area and the estimated value would not affect the
trend of cardiac output variation over time [2]. A large varia-
tion in cardiac output can only be underestimated by failing to
take into account the concomitant change in aortic diameter,
which is necessarily in the same direction.
Figure 1
Oesophageal Doppler. (a) Schematic representation of oesophageal
Doppler probe in a patient, demonstrating the close relation between
oesophagus and descending thoracic aorta. (b) Characteristic velocity
waveform obtained in the descending aorta. The spectral representation
shows that most red blood cells (orange-white color) are moving at the
maximum velocity (close to the green envelope) during systole, and that
diastolic flow is minimal.
Figure 2
Principle of stroke volume calculation from aortic velocity (VAo)
measurements. The area under the maximum aortic velocity envelope
(VTI) represents the stroke distance. Assuming that all red blood cells
are moving at maximum velocity and that aortic cross-sectional area is
constant during systole, stroke volume is obtained by multiplying stroke
distance by aortic cross-sectional area.Critical Care    June 2002 Vol 6 No 3 Berton and Cholley
Finally, some manufacturers of oesophageal Doppler devices
provide measures of systemic cardiac output rather than of
descending aortic blood flow. They calculate the systemic
values by assuming a constant partition of blood between
cephalic (30%) and caudal (70%) territories. Although this
may be valid in healthy, resting persons, the partition may vary
depending on haemodynamic conditions, reflex activation, or
metabolic activity within different organs. Therefore, the
assumed constant ratio between cephalic and caudal territo-
ries (7:3) may become inaccurate under a variety of patho-
physiological conditions [2–4].
Learning curve and reproducibility
Oesophageal Doppler is a simple technique, and most users
acknowledge that it is fairly easy to achieve adequate probe
positioning and to obtain reproducible results [5,6]. Investiga-
tors who studied the learning curve with the technique [7,8]
noted a dramatic improvement in the skills of untrained opera-
tors after performing only 10 or 12 probe placements. Inter-
observer variability has been shown to be less than 10% and
intraobserver variability is only 8% – a figure that is closer to
12% for thermodilution [2,5,9,10].
Probe displacement can occur during prolonged monitoring
as a result of various factors (nursing procedures, deglutition
and gravity, among others), and results in a poorly defined
velocity envelope or loss of signal. It is therefore mandatory to
recheck the signal quality, on a systematic basis, before
acquiring and interpreting Doppler-derived data. Failure to
reposition the probe before each measurement may lead to
grossly erroneous cardiac output values.
Validation of cardiac output measurement using
oesophageal Doppler
‘Gold standard’ techniques for cardiac output measurement,
such as aortic electromagnetic or ultrasound transit time
flowmetry, are highly invasive and cannot be used in patients.
Clinically available techniques include the Fick principle, dye
dilution, thermodilution and transthoracic echo Doppler.
These techniques are less accurate and reproducible, and
none of them has ever been validated in comparison with a
‘gold standard’ technique in critically ill, mechanically venti-
lated patients. The widespread use of thermodilution in inten-
sive care units has made it a ‘reference’ technique, despite its
well-known pitfalls [11]. Therefore, all trials aimed at validat-
ing cardiac output measurement using oesophageal Doppler
have compared this technique with thermodilution. Such
studies [2,5,7,9,12] generally found a rather poor agreement
between the two techniques, but suggested that the differ-
ence in measures of cardiac output was consistent (i.e. a
change in cardiac output with one technique was matched by
a proportionate change with the other technique).
More recently, a multicentre study compared multiple tech-
niques with oesophageal Doppler [10]. Patients from three dif-
ferent intensive care units underwent paired cardiac output
measurements using thermodilution and oesophageal Doppler.
In addition, simultaneous suprasternal Doppler and indirect
calorimetry (Fick principle) were used to measure cardiac
output in some patients from one centre. Good correlation was
found between thermodilution and oesophageal Doppler
(r = 0.95), with a small systematic underestimation (bias
0.24 l/min) using oesophageal Doppler. The limits of agree-
ment between thermodilution and oesophageal Doppler were
+2 l/min to –1.5 l/min. Variations in cardiac output between
two consecutive measurements using either oesophageal
Doppler or thermodilution techniques were similar in direction
and magnitude (bias 0 l/min; limits of agreement ±1.7 l/min;
Fig. 3). Suprasternal Doppler and indirect calorimetry yielded
similar correlations and agreement in the subset of patients in
which they were used. These findings confirmed that
oesophageal Doppler can provide a noninvasive, clinically
useful estimate of cardiac output, and may detect haemody-
namic changes in mechanically ventilated, critically ill patients.
Methods using Fick Principle
In 1870, Fick described the first method to estimate cardiac
output in humans. Fick postulated that oxygen uptake in the
lungs is entirely transferred to the blood. Therefore, cardiac
output can be calculated as the ratio between oxygen consump-
tion (VO2) and arteriovenous difference in oxygen (AVDO2).
VO2 Fick equation: Cardiac output (CO) = (1)
AVDO2
This estimation is accurate when the haemodynamic status is
sufficiently stable to allow constant gas diffusion during the
mean transit time of blood through the lungs.
Devices that measure VO2, such as the Delta-Trach (Datex,
Helsinki, Finland) indirect calorimetry monitor, can be used to
calculate cardiac output. However, this technique has a
number of practical limitations: it requires central venous and
arterial catheters for mixed venous and arterial blood sam-
pling in order to compute AVDO2; and it cannot be used in
patients ventilated with a fractional inspired oxygen (FiO2)
greater than 60% because of the poor accuracy of the para-
magnetic oxygen sensors that measured inspired and expired
fractions of oxygen [13]. Therefore, this technique is often not
applicable in critically ill patients, because they require
extreme ventilatory conditions with high FiO2 or because their
haemodynamic status is unstable.
The Fick principle can be applied to any gas diffusing through
the lungs, including carbon dioxide. A new monitor called
NICO (Novametrix Medical Systems, Inc., Wallingford, CT,
USA) is based on application of the Fick principle to carbon
dioxide in order to estimate cardiac output noninvasively, using
intermittent partial rebreathing through a specific disposable
rebreathing loop. The monitor consists of a carbon dioxide
sensor (infrared light absorption), a disposable airflow sensor(differential pressure pneumotachometer) and a pulse
oxymeter. VCO2 is calculated from minute ventilation and its
carbon dioxide content, whereas the arterial carbon dioxide
content (CaCO2) is estimated from end-tidal carbon dioxide
(etCO2), with adjustments for the slope of the carbon dioxide
dissociation curve and the degree of dead space ventilation.
The partial rebreathing reduces carbon dioxide elimination and
increases etCO2. Measurements under normal and rebreathing
conditions allow one to omit the venous carbon dioxide content
(CvCO2) measurement in the Fick equation (see below), and
therefore the need for a central venous access is eliminated.
The principle used by the NICO monitor is as follows.
Fick equation applied to carbon dioxide: 
VCO2 CO = (2)
CvCO2 – CaCO2
Assuming that cardiac output remains unchanged under
normal (N) and rebreathing (R) conditions:
VCO2N VCO2R CO =                                    = (3)
CvCO2N – CaCO2N CvCO2R – CaCO2R
By subtracting the normal and rebreathing ratios, the follow-
ing differential Fick equation is obtained:
VCO2N – VCO2R CO = (4)
(CvCO2N – CaCO2N) – (CvCO2R – CaCO2R)
Because carbon dioxide diffuses quickly in blood (22 times
faster than oxygen), one can assume that CvCO2 does not
differ between normal and rebreathing conditions, and there-
fore the venous contents disappear from the equation.
∆VCO2 CO = (5)
∆CaCO2
The delta in CaCO2 can be approximated by the delta in
etCO2 multiplied by the slope (S) of the carbon dioxide disso-
ciation curve. This curve represents the relation between
carbon dioxide volumes (used to calculate carbon dioxide
content) and partial pressure of carbon dioxide. This relation
can be considered linear between 15 and 70 mmHg of partial
pressure of carbon dioxide [14].
∆VCO2 CO = (6)
S × ∆etCO2
Because changes in VCO2 and etCO2 only reflect the blood
flow that participates in gas exchange, an intrapulmonary
shunt can affect estimation of cardiac output using the NICO
device. To take this into account, the monitor estimates the
shunting fraction using a measured peripheral oxygen satura-
tion of haemoglobin combined with the FiO2 and the arterial
oxygen tension measured in arterial blood gases, according
to Nunn’s iso-shunt tables [15].
Increased intrapulmonary shunt and poor haemodynamic sta-
bility (which are not uncommon in critically ill patients) are
likely to alter the precision of cardiac output estimation by the
NICO monitor. The first published clinical and experimental
validation studies [16–18] reported a relatively loose agree-
ment (bias ±1.8 l/min) between cardiac output measured
using thermodilution and NICO (this is similar to standard
observations whenever a technique is compared with thermo-
dilution). Those investigators therefore concluded that the
technique is not yet ready to be substituted to thermodilution.
However, comparable limits of agreements have been
observed in many studies that compared cardiac output mea-
surement techniques with thermodilution, including ‘bolus’
versus ‘continuous’ thermodilution [10,19,20]. Bland and
Altman [21] asserted that tight agreement is impossible to
obtain when the method used for reference is not very
precise itself. In our opinion, such limits of agreement do not
preclude the potential usefulness of cardiac output measure-
ment using NICO, although the above-mentioned limitations
must be kept in mind and the technique is to be used in only
the most appropriate patients.
It is also important to note that the patient must be under fully
controlled mechanical ventilation if the NICO monitor is to be
used. In addition, arterial blood samples are required to enter
arterial oxygen tension values for shunt estimation, which
somewhat tempers the noninvasive nature of this technique.
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Figure 3
Eighty-eight paired measurements of cardiac output (CO) variations
between two time-points obtained simultaneously using thermodilution
(TH) with a pulmonary artery catheter and oesophageal Doppler (ED).
Ideal agreement is represented by a horizontal line. Contradictory
information with the two techniques was observed in only three cases
[10]. The open boxes and vertical bars indicate mean and standard
deviation, respectively.Pulse contour cardiac output
The first attempt to determine stroke volume from the shape of
the arterial pulse curve can be tracked as far back as 1904
[22]. The aortic pressure waveform results from the interaction
between stroke volume and the mechanical characteristics of
the arterial tree. Many models have been proposed to
describe the physical properties of the arterial tree. The sim-
plest model, which is used routinely in clinical practice, con-
sists of a single resistance (peripheral resistance) to represent
arteriolar tone (i.e. the degree of vasoconstriction of the small
arteries); this determines the value of mean arterial pressure
for a given flow. However, peripheral resistance alone cannot
account for the shape of the arterial pulse curve (Fig. 4, first
model). In order to improve the arterial model with respect to
its ability to reproduce the shape of the aortic pressure wave-
form, other elements must be incorporated. For example,
adding a capacitance element allows one to generate a more
physiological pulse pressure wave (Fig. 4, second model), and
an additional resistance that represents the characteristic
aortic impedance renders the predicted waveform very similar
to its measured counterpart (Fig. 4, third model) [23].
In contrast to the concept presented in Fig. 4, pulse contour
methods use the pressure waveform as an input for a model
of the systemic circulation in order to predict instantaneous
flow. The pressure waveform is not obtained from the aorta
itself but rather from a peripheral artery (radial or femoral),
which requires assumptions to be made regarding the
changes in pulse shape between these different locations.
The models used to represent the systemic circulation may
vary according to specific pulse contour device, and include
the following: the three-element ‘Windkessel’ model (as in the
example presented in Fig. 4) [24,25], or more sophisticated
models that allow one to account for finite pulse wave veloc-
ity and wave reflection phenomena [26]. The values attributed
to model parameters (resistance, compliance and character-
istic impedance) are initially estimated according to the
patient’s sex and age, and from the pressure waveform. They
are then refined following a calibration of mean cardiac
output using an indicator dilution technique: transpulmonary
thermodilution for the PiCCO (Pulsion Medical Systems,
Munich, Germany) [27] or lithium chloride dilution for the
PULSECO (LiDCO Ltd, Cambridge, UK) [28].
Regardless of the model used, the accuracy of flow predic-
tion is greatly increased after initial calibration [25]. By pro-
viding a reference value for peripheral resistance (ratio of
mean arterial pressure to mean systemic flow), this calibra-
tion allows the system to compute more precisely the other
parameters that represent arterial mechanical properties
and to obtain a better estimation of cardiac output. Recali-
brating every 4 hours (or at least before any important data
acquisition) may augment the accuracy of pulse contour
estimated cardiac output in critically ill patients, who are
likely to exhibit frequent changes in degree of arteriolar
vasoconstriction [26].
Several studies have compared cardiac output as measured
using thermodilution and pulse contour [26,29,30], and found
fair agreement between values obtained using the two tech-
niques. However, patients who had poorly defined arterial
waveforms or who presented with arrhythmia were always
excluded because pulse contour methods cannot provide
reliable results in such conditions. The limits of agreement are
always quite loose (close to ±1.5 l/min), as is usual when
thermodilution is used as a reference method. A similar
agreement was found in a group of patients with septic shock
and who were receiving catecholamines [25], indicating that
this technique appears quite robust in critically ill patients.
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Figure 4
Illustration of the importance of various arterial mechanical properties
in generating the aortic pressure waveform. With the measured
instantaneous flow [Q(t)] as an input, a single resistance (R) model of
the circulation (model 1) would generate a pressure waveform [P(t)]
with morphology identical to that of the flow waveform, differing only in
magnitude by a factor of R. When arterial compliance, represented by
a capacitance element (C), is incorporated (model 2), the predicted
pressure waveform begins to exhibit many of the morphological
characteristics of its measured counterpart. If a third element
representing characteristic impedance (Z) is introduced (model 3), the
morphologies of the predicted and measured pressure waveforms
become very similar [23].Conclusion
Several ‘new’ techniques are now available that provide
easier cardiac output measurement. None of them emerges
as more accurate than the others, although no formal compar-
isons have yet been attempted. They are still relatively inva-
sive, requiring either sedation and mechanical ventilation for
oesophageal Doppler and Fick/carbon dioxide methods, or
arterial and central venous access for pulse contour tech-
niques. Oesophageal Doppler is operator dependent, training
is required to obtain ‘optimal’ aortic velocity signals, and
probe repositioning is mandatory if reliable results are to be
obtained. The pulse contour methods also require frequent
calibration, and the need for both arterial and central venous
catheters preclude their routine use in the operating room.
Unlike Doppler and pulse contour, the Fick/carbon dioxide
method does not provide an instantaneous measure of
cardiac output, but rather a mean value every 3 min. No
visible, real-time signal allows the operator to make a critical
judgement based on the cardiac output values obtained. This
promising technique still requires more extensive validation in
critically ill patients, who are haemodynamically unstable and
who have lung disease with increased shunt.
These techniques do not exclude each other because their
advantages and limitations are quite different. They also are
not intended to replace the pulmonary artery catheter, which
remains quite unique in providing pressures (right atrial, pul-
monary artery and pulmonary ‘wedged’ pressures) as well as
venous oxygen saturation, in addition to cardiac output.
These parameters are still extremely useful in the manage-
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